Paugh SW, Bonten EJ, Savic D, Ramsey LB, Thierfelder WE, Gurung P, Malireddi RKS, Actis M, Mayasundari A, Min J, et al
Jahraus explained the importance of an individuals relationship with food during eating disorder treatment, stating that lack of appetite and increased restriction while using a GLP-1RA could have negative impacts on treatment
Short-term appetite suppressants The FDA has approved four drugs for short-term use because they are stimulants classified as schedule III or IV drugs and may lead to dependency
Despite the promising potential of GLP-1 RAs, it is essential to conduct further clinical studies to confirm their long-term efficacy and safety in patients with HFpEF
Refer 3 & Yours is Free: Offer free medication to your audience through our unique referral program